Stony Brook Kidney Center, Dci is a medicare approved dialysis facility center in East Setauket, New York and it has 26 dialysis stations. It is located in Suffolk county at 26 Research Way, East Setauket, NY, 11733. You can reach out to the office of Stony Brook Kidney Center, Dci at (631) 444-0502. This dialysis clinic is managed and/or owned by Dialysis Clinic, Inc.. Stony Brook Kidney Center, Dci has the following ownership type - Non-Profit. It was first certified by medicare in August, 1997. The medicare id for this facility is 332570 and it accepts patients under medicare ESRD program.
| Name | Stony Brook Kidney Center, Dci |
|---|---|
| Location | 26 Research Way, East Setauket, New York |
| No. of Dialysis Stations | 26 |
| Medicare ID | 332570 |
| Managed By | Dialysis Clinic, Inc. |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 26 Research Way, East Setauket, New York, 11733 | |
| (631) 444-0502 | |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
| NPI Number | 1861425241 |
| Doing Business As | Dialysis Clinic Inc. |
| Address | 26 Research Way East Setauket, New York, 11733 |
| Phone Number | (631) 444-0502 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 72% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 17% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 11% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 62% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 28% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 14% |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 64% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 25% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 11% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 61% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 34% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 12% |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 83% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 17% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 65% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 31% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 4% | 12% |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 90 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 1 |
| Medicare patients who had average hemoglobin (hgb) greater than 12 g/dL | 2 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 147 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1318 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Pediatic patients getting regular hemodialysis at the center | 2 |
| Pediatric patient months included in in Kt/V greater than or eqaul to 1.2 | 3 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 24 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 221 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 75 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Stony Brook Kidney Center, Dci with elevated calcium levels.
| Patients with hypercalcemia | 177 |
| Hypercalcemia patient months | 1627 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 184 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 24 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 120 |
| Patient months included in arterial venous fistula and catheter summaries | 1036 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 76 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 5 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 145 |
| Hospitalization Rate in facility | 213 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 316.8 |
| Hospitalization Rate: Lower Confidence Limit | 152 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Stony Brook Kidney Center, Dci were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 26.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 35.8 |
| Readmission Rate: Lower Confidence Limit | 18.5 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Stony Brook Kidney Center, Dci get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .24 (Better than Expected) |
| SIR: Upper Confidence Limit | .8 |
| SIR: Lower Confidence Limit | .04 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Stony Brook Kidney Center, Dci's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 118 |
| Transfusion Rate in facility | 42 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 81.8 |
| Transfusion Rate: Lower Confidence Limit | 23.4 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Stony Brook Kidney Center, Dci lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 774 |
| Mortality Rate in facility | 12.8 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 16.2 |
| Mortality Rate: Lower Confidence Limit | 10 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago
Stony Brook Kidney Center, Dci Location: 26 Research Way, East Setauket, New York, 11733 Phone: (631) 444-0502 |
News Archive
Jazzercise, the world's leading dance fitness program, is proud to announce its partnership with Back in the Swing USA®, a grassroots nonprofit organization exclusively dedicated to providing awareness, access and financial support for breast cancer survivorship programs and academic medical research in the field of breast cancer survivorship.
Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) is pleased to announce the completion of its 2009 AGM. Shareholders elected Greg Peet (as Chairman), Troy Griffiths, Harry Jaako, Stephen Martin and Tanner Philp as Directors of Vigil. KPMG LLP was appointed auditors of Vigil. The shareholders also approved an amendment to the Omnibus Plan to increase the number of Common Shares reserved for issuance under the Omnibus Plan to 15,000,000 Common Shares (being approximately 15.0% of the total outstanding Common Shares of the Company).
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 6 days ago